SCHEMBL27892181

SCHEMBL27892181

COC(=O)N(N)c1ncncn1

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.31
ATM Q13315 1/20 0.31
HSP90AA1 P07900 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27781704 0.80 NFKB1 (0.32)
SCHEMBL27523363 0.74 P2RX7 (0.39) P2RX7HSP90AA1
SCHEMBL5157780 0.69 MLYCD (0.33)
Pyrimidine SCHEMBL28193431 0.68 P2RX7 (0.41) P2RX7
Pyridine SCHEMBL28193390 0.67 P2RX7 (0.37) P2RX7
SCHEMBL5264575 0.66 RAB9A (0.39)
SCHEMBL28755305 0.66 ALDH1A1 (0.39)
SCHEMBL9272029 0.65 ALDH1A1 (0.42) HSP90AA1
SCHEMBL4919254 0.64 NPSR1 (0.42) ATM
SCHEMBL4107497 0.64 L3MBTL1 (0.47) ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102971323-A Heterocyclic compounds as JANUS kinase inhibitors BIOCRYST PHARM INC 2013-03-13 CN disclosed